Thermo Fisher Scientific (TMO) Financials
Thermo Fisher Scientific (TMO) Historical Financial Statements and Key Metrics for 1994 - 2026
Full Thermo Fisher Scientific financials for 1994 - 2026 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Thermo Fisher Scientific Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2026-Jun-27 | 11,994 | 4,943 (41.2 %) | 2,087 (17.4 %) | 1,736 (14.5 %) | 2,572 | 4.68 |
| 2026-Mar-28 | 11,005 | 4,476 (40.7 %) | 1,863 (16.9 %) | 1,651 (15.0 %) | 2,310 | 4.43 |
| 2025-Dec-31 | 12,215 | 4,636 (38.0 %) | 2,302 (18.8 %) | 1,975 (16.2 %) | 3,215 | 5.21 |
| 2025-Sep-27 | 11,122 | 4,652 (41.8 %) | 1,943 (17.5 %) | 1,616 (14.5 %) | 2,838 | 4.27 |
| 2025-Jun-28 | 10,855 | 4,048 (37.3 %) | 1,917 (17.7 %) | 1,617 (14.9 %) | 2,798 | 4.28 |
| 2025-Mar-29 | 10,364 | 4,235 (40.9 %) | 1,716 (16.6 %) | 1,507 (14.5 %) | 1,716 | 3.98 |
| 2024-Dec-31 | 11,395 | 4,903 (43.0 %) | 2,016 (17.7 %) | 1,830 (16.1 %) | 3,000 | 4.78 |
Full historical income statements for 1994 - 2026 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2026-Jun-27 | 113,174 | 60,488 | 42,549 | 52,679 | 4,064 |
| 2026-Mar-28 | 113,281 | 61,341 | 43,161 | 51,940 | 3,256 |
| 2025-Dec-31 | 110,343 | 56,807 | 40,855 | 53,407 | 10,110 |
| 2025-Sep-27 | 103,020 | 51,996 | 35,680 | 51,024 | 3,546 |
| 2025-Jun-28 | 101,230 | 50,628 | 35,229 | 50,511 | 6,390 |
| 2025-Mar-29 | 99,041 | 49,555 | 34,189 | 49,357 | 5,947 |
| 2024-Dec-31 | 97,321 | 47,650 | 31,275 | 49,551 | 5,570 |
Full historical balance sheet data for 1994 - 2026 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2026-Jun-27 | 2,125 | 164 | -2,571 | 1,675 |
| 2026-Mar-28 | 1,192 | -8,961 | 1,093 | 816 |
| 2025-Dec-31 | 3,457 | 891 | 3,526 | 2,992 |
| 2025-Sep-27 | 2,239 | -4,123 | -632 | 1,835 |
| 2025-Jun-28 | 1,399 | -288 | -991 | 1,105 |
| 2025-Mar-29 | 723 | -527 | -102 | 361 |
| 2024-Dec-31 | 3,290 | 20 | -3,666 | 2,810 |
Full historical cash flow data for 1994 - 2026 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2026-Jun-27 | 190,334 | 228,819 | 15.87 | 27.41 | 3.61 |
| 2026-Mar-28 | 176,090 | 215,997 | 16.00 | 26.65 | 3.39 |
| 2025-Dec-31 | 217,873 | 248,871 | 17.84 | 27.58 | 4.08 |
| 2025-Sep-27 | 175,483 | 209,181 | 15.78 | 27.15 | 3.44 |
| 2025-Jun-28 | 154,330 | 184,983 | 14.22 | 23.86 | 3.06 |
| 2025-Mar-29 | 189,060 | 219,115 | 18.24 | 31.36 | 3.83 |
| 2024-Dec-31 | 199,168 | 226,434 | 17.48 | 27.21 | 4.02 |
Full historical valuation and operating metrics for 1994 - 2026 are included in the
US Historical Financials dataset.